Previous Article | Next Article 
Journal of Virology, May 2000, p. 4127-4138, Vol. 74, No. 9
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Anti-Human Immunodeficiency Virus Type 1 (HIV-1)
CD8+ T-Lymphocyte Reactivity during Combination
Antiretroviral Therapy in HIV-1-Infected Patients with
Advanced Immunodeficiency
Charles R.
Rinaldo Jr.,1,2,*
Xiao-Li
Huang,1
Zheng
Fan,1
Joseph B.
Margolick,3
Luann
Borowski,1
Aki
Hoji,1
Christine
Kalinyak,1
Deborah K.
McMahon,1,2
Sharon A.
Riddler,1,2
William H.
Hildebrand,4
Richard B.
Day,1 and
John W.
Mellors1,2,5
Graduate School of Public
Health1 and School of
Medicine,2 University of Pittsburgh, and
the Veterans Affairs Medical Center,5
Pittsburgh, Pennsylvania 15261; Johns Hopkins School of Hygiene
and Public Health, Baltimore, Maryland 212053;
and University of Oklahoma Health Sciences Center, Oklahoma
City, Oklahoma 731904
Received 17 December 1999/Accepted 29 January 2000
The long-term efficacy of combination antiretroviral therapy may
relate to augmentation of anti-human immunodeficiency virus type 1 (HIV-1) CD8+ T-cell responses. We found that prolonged
treatment of late-stage HIV-1-infected patients with a protease
inhibitor and two nucleoside reverse transcriptase inhibitors failed to
restore sustained, high levels of HIV-1-specific, HLA class
I-restricted, cytotoxic-T-lymphocyte precursors and gamma interferon
(IFN-
) production by CD8+ T cells. In some patients,
particularly those initiating three-drug combination therapy
simultaneously rather than sequentially, there were early, transient
increases in the frequency of anti-HIV-1 CD8+ T cells that
correlated with decreases in HIV-1 RNA and increases in T-cell counts.
In the other patients, HIV-1-specific T-cell functions either failed to
increase or declined from baseline during triple-drug therapy, even
though some of these patients showed suppression of plasma HIV-1 RNA.
These effects of combination therapy were not unique to HIV-1 specific
T-cell responses, since similar effects were noted for CD8+
T cells specific for the cytomegalovirus pp65 matrix protein. The level
and breadth of CD8+ cell reactivity to HLA A*02 HIV-1
epitopes, as determined by IFN-
production and HLA tetramer staining
after combination therapy, were related to the corresponding responses
prior to treatment. There was, however, a stable, residual population
of potentially immunocompetent HIV-1-specific T cells remaining after
therapy, as shown by tetramer staining of CD8+
CD45RO+ cells. These results indicate that new strategies
will be needed to target residual, immunocompetent HIV-1-specific
CD8+ T cells to enhance the effectiveness of antiretroviral
therapy in patients with advanced immunodeficiency.
*
Corresponding author. Mailing address: A427 Crabtree
Hall, University of Pittsburgh Graduate School of Public Health, 130 DeSoto St., Pittsburgh, PA 15261. Phone: (412) 624-3928. Fax: (412)
624-4953. E-mail: rinaldo+{at}pitt.edu.
Journal of Virology, May 2000, p. 4127-4138, Vol. 74, No. 9
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Whiteside, T. L., Piazza, P., Reiter, A., Stanson, J., Connolly, N. C., Rinaldo, C. R. Jr., Riddler, S. A.
(2009). Production of a Dendritic Cell-Based Vaccine Containing Inactivated Autologous Virus for Therapy of Patients with Chronic Human Immunodeficiency Virus Type 1 Infection. CVI
16: 233-240
[Abstract]
[Full Text]
-
Huang, X.-L., Fan, Z., Borowski, L., Rinaldo, C. R.
(2008). Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8+ T cell immunity. J. Leukoc. Biol.
83: 1530-1540
[Abstract]
[Full Text]
-
Schaubert, K. L., Price, D. A., Frahm, N., Li, J., Ng, H. L., Joseph, A., Paul, E., Majumder, B., Ayyavoo, V., Gostick, E., Adams, S., Marincola, F. M., Sewell, A. K., Altfeld, M., Brenchley, J. M., Douek, D. C., Yang, O. O., Brander, C., Goldstein, H., Kan-Mitchell, J.
(2007). Availability of a Diversely Avid CD8+ T Cell Repertoire Specific for the Subdominant HLA-A2-Restricted HIV-1 Gag p2419-27 Epitope. J. Immunol.
178: 7756-7766
[Abstract]
[Full Text]
-
Ibarrondo, F. J., Anton, P. A., Fuerst, M., Ng, H. L., Wong, J. T., Matud, J., Elliott, J., Shih, R., Hausner, M. A., Price, C., Hultin, L. E., Hultin, P. M., Jamieson, B. D., Yang, O. O.
(2005). Parallel Human Immunodeficiency Virus Type 1-Specific CD8+ T-Lymphocyte Responses in Blood and Mucosa during Chronic Infection. J. Virol.
79: 4289-4297
[Abstract]
[Full Text]
-
Huang, X.-L., Fan, Z., Colleton, B. A., Buchli, R., Li, H., Hildebrand, W. H., Rinaldo, C. R. Jr.
(2005). Processing and Presentation of Exogenous HLA Class I Peptides by Dendritic Cells from Human Immunodeficiency Virus Type 1-Infected Persons. J. Virol.
79: 3052-3062
[Abstract]
[Full Text]
-
Sharpe, S. A., Cope, A., Dowall, S., Berry, N., Ham, C., Heeney, J. L., Hopkins, D., Easterbrook, L., Dennis, M., Almond, N., Cranage, M.
(2004). Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant epitope. J. Gen. Virol.
85: 2591-2602
[Abstract]
[Full Text]
-
Gushue, G. V., Brazaitis, S. J.
(2003). Lazarus and Group Psychotherapy: AIDS in the Era of Protease Inhibitors. The Counseling Psychologist
31: 314-342
[Abstract]
-
Fitzgerald, J. C., Gao, G.-P., Reyes-Sandoval, A., Pavlakis, G. N., Xiang, Z. Q., Wlazlo, A. P., Giles-Davis, W., Wilson, J. M., Ertl, H. C. J.
(2003). A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag. J. Immunol.
170: 1416-1422
[Abstract]
[Full Text]
-
Vogel, T. U., Horton, H., Fuller, D. H., Carter, D. K., Vielhuber, K., O'Connor, D. H., Shipley, T., Fuller, J., Sutter, G., Erfle, V., Wilson, N., Picker, L. J., Watkins, D. I.
(2002). Differences Between T Cell Epitopes Recognized After Immunization and After Infection. J. Immunol.
169: 4511-4521
[Abstract]
[Full Text]
-
Abbas, U. L., Mellors, J. W.
(2002). Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: Risk without reward. Proc. Natl. Acad. Sci. USA
99: 13377-13378
[Full Text]
-
Wang, Q. J., Huang, X.-L., Rappocciolo, G., Jenkins, F. J., Hildebrand, W. H., Fan, Z., Thomas, E. K., Rinaldo, C. R. Jr
(2002). Identification of an HLA A*0201-restricted CD8+ T-cell epitope for the glycoprotein B homolog of human herpesvirus 8. Blood
99: 3360-3366
[Abstract]
[Full Text]
-
Zhao, X.-Q., Huang, X.-L., Gupta, P., Borowski, L., Fan, Z., Watkins, S. C., Thomas, E. K., Rinaldo, C. R. Jr.
(2002). Induction of Anti-Human Immunodeficiency Virus Type 1 (HIV-1) CD8+ and CD4+ T-Cell Reactivity by Dendritic Cells Loaded with HIV-1 X4-Infected Apoptotic Cells. J. Virol.
76: 3007-3014
[Abstract]
[Full Text]
-
Ortiz, G. M., Hu, J., Goldwitz, J. A., Chandwani, R., Larsson, M., Bhardwaj, N., Bonhoeffer, S., Ramratnam, B., Zhang, L., Markowitz, M. M., Nixon, D. F.
(2002). Residual Viral Replication during Antiretroviral Therapy Boosts Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses in Subjects Treated Early after Infection. J. Virol.
76: 411-415
[Abstract]
[Full Text]
-
McKay, P. F., Schmitz, J. E., Barouch, D. H., Kuroda, M. J., Lifton, M. A., Nickerson, C. E., Gorgone, D. A., Letvin, N. L.
(2002). Vaccine Protection Against Functional CTL Abnormalities in Simian Human Immunodeficiency Virus-Infected Rhesus Monkeys. J. Immunol.
168: 332-337
[Abstract]
[Full Text]
-
Ortiz, G. M., Wellons, M., Brancato, J., Vo, H. T. T., Zinn, R. L., Clarkson, D. E., Van Loon, K., Bonhoeffer, S., Miralles, G. D., Montefiori, D., Bartlett, J. A., Nixon, D. F.
(2001). Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects. Proc. Natl. Acad. Sci. USA
10.1073/pnas.221452198v1
[Abstract]
[Full Text]
-
Casazza, J. P., Betts, M. R., Picker, L. J., Koup, R. A.
(2001). Decay Kinetics of Human Immunodeficiency Virus-Specific CD8+ T Cells in Peripheral Blood after Initiation of Highly Active Antiretroviral Therapy. J. Virol.
75: 6508-6516
[Abstract]
[Full Text]
-
Fan, Z., Huang, X.-L., Borowski, L., Mellors, J. W., Rinaldo, C. R. Jr.
(2001). Restoration of Anti-Human Immunodeficiency Virus Type 1 (HIV-1) Responses in CD8+ T Cells from Late-Stage Patients on Prolonged Antiretroviral Therapy by Stimulation In Vitro with HIV-1 Protein-Loaded Dendritic Cells. J. Virol.
75: 4413-4419
[Abstract]
[Full Text]
-
Goepfert, P. A., Bansal, A., Edwards, B. H., Ritter, G. D. Jr., Tellez, I., McPherson, S. A., Sabbaj, S., Mulligan, M. J.
(2000). A Significant Number of Human Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes Detected by Tetramer Binding Do Not Produce Gamma Interferon. J. Virol.
74: 10249-10255
[Abstract]
[Full Text]
-
Ortiz, G. M., Wellons, M., Brancato, J., Vo, H. T. T., Zinn, R. L., Clarkson, D. E., Van Loon, K., Bonhoeffer, S., Miralles, G. D., Montefiori, D., Bartlett, J. A., Nixon, D. F.
(2001). Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects. Proc. Natl. Acad. Sci. USA
98: 13288-13293
[Abstract]
[Full Text]